Shun-Ichiro Ogura Selected Research

Shun-Ichiro Ogura Research Topics

Disease

33	Neoplasms (Cancer) 03/2022 - 04/2006
5	Glioma (Gliomas) 03/2022 - 06/2012
5	Urinary Bladder Neoplasms (Bladder Cancer) 02/2022 - 09/2013
4	Carcinoma (Carcinomatosis) 12/2014 - 12/2008
3	Stomach Neoplasms (Stomach Cancer) 09/2015 - 09/2012
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2012 - 12/2008
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2012 - 04/2007
2	Brain Neoplasms (Brain Tumor) 11/2011 - 09/2011
1	Hypotension (Low Blood Pressure) 03/2022
1	Urologic Neoplasms (Urological Cancer) 02/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2021
1	Kidney Neoplasms (Kidney Cancer) 09/2021
1	Prostatic Neoplasms (Prostate Cancer) 09/2021
1	Neoplasm Metastasis (Metastasis) 03/2017
1	Hypoxia (Hypoxemia) 01/2015
1	Peritoneal Neoplasms 12/2014
1	Ovarian Neoplasms (Ovarian Cancer) 12/2014
1	Malaria 12/2013

Drug/Important Bio-Agent (IBA)

23	AcidsIBA 03/2022 - 09/2011
22	protoporphyrin IXIBA 09/2021 - 04/2006
13	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022 - 01/2012
7	Photosensitizing Agents (Photosensitizers)IBA 02/2022 - 01/2012
6	PorphyrinsIBA 02/2022 - 09/2011
6	Aminolevulinic Acid (Levulan)FDA Link 05/2021 - 02/2014
3	Tumor Biomarkers (Tumor Markers)IBA 02/2022 - 12/2008
3	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2022 - 02/2013
3	LigandsIBA 01/2022 - 01/2017
3	Heme (Haem)IBA 01/2017 - 12/2013
3	ATP-Binding Cassette Transporters (ABC Transporters)IBA 07/2015 - 09/2011
3	Adenosine Triphosphate (ATP)IBA 03/2014 - 09/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2019
2	Lanthanoid Series Elements (Lanthanides)IBA 01/2017 - 09/2015
2	ProdrugsIBA 01/2015 - 06/2012
2	Proteins (Proteins, Gene)FDA Link 03/2014 - 12/2008
2	Messenger RNA (mRNA)IBA 09/2013 - 11/2011
2	Conditioned Culture MediaIBA 10/2012 - 12/2008
2	proneurotensinIBA 10/2012 - 12/2008
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2022
1	Biological ProductsIBA 02/2022
1	diphenyl (biphenyl)IBA 01/2022
1	Sunitinib (Sutent)FDA Link 09/2021
1	Therapeutic UsesIBA 09/2021
1	Member 2 Subfamily G ATP Binding Cassette TransporterIBA 09/2021
1	Pharmaceutical PreparationsIBA 09/2020
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 09/2020
1	Schiff Bases (Schiff Base)IBA 12/2017
1	Contrast MediaIBA 03/2017
1	GadoliniumIBA 03/2017
1	CarbohydratesIBA 01/2017
1	MonosaccharidesIBA 01/2017
1	IronIBA 01/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	Growth InhibitorsIBA 11/2016
1	CyclinsIBA 01/2015
1	Adenosine Triphosphatases (ATPase)IBA 01/2015
1	Oxygen (Dioxygen)IBA 01/2015
1	EnzymesIBA 01/2015
1	PC 16IBA 12/2014
1	neuromedin NIBA 10/2012
1	NeurotensinIBA 10/2012
1	AntibodiesIBA 10/2012
1	Peptides (Polypeptides)IBA 09/2012
1	Radiation-Sensitizing AgentsIBA 06/2012
1	MetalloporphyrinsIBA 01/2012
1	Coproporphyrinogen Oxidase (Coproporphyrinogen III Oxidases)IBA 11/2011
1	Protein Kinase InhibitorsIBA 09/2011
1	ErbB Receptors (EGF Receptor)IBA 04/2007
1	HematoporphyrinsIBA 04/2006
1	Singlet OxygenIBA 04/2006

Therapy/Procedure

17	Photochemotherapy (Photodynamic Therapy) 02/2022 - 01/2012
8	Therapeutics 09/2021 - 04/2006
2	Drug Therapy (Chemotherapy) 05/2021 - 02/2014
1	Controlled Hypotension 03/2022
1	Hyperthermic Intraperitoneal Chemotherapy 12/2014
1	Cytoreduction Surgical Procedures 12/2014
1	Oral Administration 02/2014
1	Aftercare (After-Treatment) 02/2013